37 citations
,
April 2010 in “FEBS Letters” In this study, researchers reported that the activation of EDA2R by p53 leads to p53-dependent cell death in cancer cells and is involved in chemotherapy-induced hair loss.
August 2026 in “Plant Science Today” This review synthesizes data on Eclipta alba, highlighting its traditional use for liver, skin, and general health, supported by preclinical evidence of hepatoprotective and other beneficial activities, while noting the need for more rigorous toxicological and clinical safety studies to substantiate its therapeutic applications.
25 citations
,
May 2013 in “Experimental Dermatology” This study found that topical EGF-liposomal solution may protect hair follicles from chemotherapy-induced damage by inducing a catagen-like stage in a mouse model.
October 2024 in “Skin Research and Technology” In this study, extracorporeal shock wave treatment for female pattern hair loss resulted in significant increases in hair count and thickness in 20 women, with 85% of participants perceiving improvements in hair volume.
January 2024 in “Wiadomości Lekarskie” This study reports that while primary treatment for uveal melanoma has a very high success rate, treating distant metastases, particularly in the liver, remains challenging. Tebentafusp, dependent on HLA-A expression, is the first drug to extend patient survival.
29 citations
,
September 1997 in “PubMed” This paper reviews follicular hair transplantation techniques and planning, emphasizing careful evaluation and long-term strategy for achieving excellent cosmetic results.
January 2005 in “Metas de Enfermería” This review discusses the use of Serenoa repens for benign prostatic hyperplasia symptoms, noting similar efficacy to other treatments but highlights the need for further rigorous trials to confirm effectiveness.
March 2026 in “Journal of Clinical Oncology” In this study, pre-treatment with 5-α-reductase inhibitors (finasteride/dutasteride) in patients with metastatic renal cell carcinoma was associated with better immune checkpoint inhibitor effectiveness and improved progression-free and overall survival, without increasing severe side effects.
February 2026 in “Molecular Imaging and Radionuclide Therapy” In this study, male patients treated with 150 mCi of radioactive iodine showed no negative impact on fertility, but long-term studies with larger groups are needed to further assess hormonal effects and sperm health after this treatment.
September 2024 in “Acta Medica Philippina” This case report describes radiation-induced alopecia in a patient following a fluoroscopy-guided procedure, with complete hair regrowth after six months of topical minoxidil treatment.
January 2021 in “Dermatologic Therapy” Channels stay open for 24 hours, making laser treatment potentially effective for hair loss.
37 citations
,
May 2018 in “Transgender health” This study found that oral estradiol was generally effective in achieving target 17-β estradiol levels in transgender women, but often failed to suppress testosterone adequately, with variability in individual responses.
December 2022 in “IntechOpen eBooks” This source evaluates the clinical effectiveness of 308 nm monochromatic excimer phototherapy in treating moderate-to-severe alopecia areata, noting that both laser and lamp methods show promise without significant risks.
9 citations
,
June 1998 in “Dermatologic Surgery” In this pilot study, the Rapid Fire Hair Implanter Carousel facilitated graft placement in hair transplantation by reducing bleeding and operative time compared to the traditional manual method.
July 2021 in “Plastic and reconstructive surgery. Global open” This study identified specific genes involved in radiation-induced fibrosis in skin, capsule, and muscle tissues of breast cancer patients, offering insights that may help improve mitigation strategies for these side effects.
October 2022 in “Journal of Drugs in Dermatology” This study observed that both PRP and 1550 nm fractional erbium-glass laser improved AGA, with greater hair density in patients receiving the combination therapy and no side effects reported.
July 2022 in “The Egyptian Journal of Plastic and Reconstructive Surgery” This study concluded that using platelet-rich plasma in follicular unit extraction for post burn alopecia is beneficial, offering fewer hazards and complications, and a shorter recovery time compared to other hair restoration procedures.
March 2024 in “Research Square (Research Square)” In this study, scalp cooling therapy was found to be well tolerated and effective at improving hair preservation for Asian women with breast or gynecological cancers undergoing certain chemotherapy regimens, particularly weekly paclitaxel, compared to historical controls.
1 citations
,
October 2025 in “Transfusion Medicine and Hemotherapy” This review synthesizes current evidence on platelet-rich plasma for dry eye disease and reports no new results; the authors emphasize the need for standardized trials to validate these approaches.
5 citations
,
April 2017 in “The journal of investigative dermatology/Journal of investigative dermatology” This study reports on an ongoing Phase I/IIa clinical trial of ex vivo gene therapy for treating severe Recessive Dystrophic Epidermolysis Bullosa, involving six adult participants with COL7A1 mutations resulting in deficient type VII collagen production.
September 2025 in “Journal of lasers in medical sciences” This study found that thulium laser therapy significantly improved hair regrowth and patient satisfaction in individuals with androgenic alopecia, demonstrating safety and effectiveness with no reported adverse events during short-term evaluation.
21 citations
,
November 2018 in “Journal of the European Academy of Dermatology and Venereology” In this study, encorafenib combined with binimetinib was well tolerated in melanoma patients, resulting in relatively few cutaneous adverse events compared to other BRAF and MEK inhibitors.
January 2017 in “Turkiye Klinikleri Journal of Dermatology”
May 2024 in “International Society of Hair Restoration Surgery” This paper describes various emerging regenerative therapies for hair loss, such as platelet-rich plasma, exosomes, and low-level laser therapy, but it doesn't provide results or conclusions about their efficacy.
10 citations
,
October 2015 in “Medicina Clínica (english Edition)” This review discusses the therapeutic potential and safety of bioidentical recombinant human epidermal growth factor (rhEGF) for various skin and mucosa conditions and reports no new clinical results.
59 citations
,
April 2016 in “Cell Reports” This study demonstrated that EdnrB signaling promotes melanocyte stem cell proliferation and differentiation, enhancing hair and epidermal melanocyte regeneration, especially under conditions of active Wnt signaling.
January 2020 in “Springer eBooks” This review discusses platelet-rich plasma as a treatment for hair loss and reports no clinical results; the authors note its potential as a minimally invasive option alongside existing therapies.
June 2026 in “Frontiers in Medicine” This study evaluated the 308-nm excimer laser as an adjuvant treatment for frontal fibrosing alopecia and found it may stabilize hairline recession and improve erythema and perifollicular hyperkeratosis, with transient erythema as the only reported adverse effect.
January 2026 in “Journal of Hard Tissue Biology” This study found that red LED photobiomodulation significantly enhanced both the metabolic activity and proliferation of human placenta-derived pericytes, alongside increased expression of angiogenic markers, suggesting a potential non-invasive approach to aid tissue repair and vascular regeneration.
January 2017 in “SM dermatology journal” This article presents eyebrow transplantation techniques developed from over 1,000 procedures at the authors' clinic, with no new clinical outcomes reported.